Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA

NCT03307941 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Suspended collaboration with the company providing the study drug

Conditions

Adenocarcinoma of the Esophagus
Adenocarcinoma of the Gastroesophageal Junction
Squamous Cell Carcinoma of the Esophagus

Interventions

DRUG: Monalizumab
DRUG: Oxaliplatin
DRUG: 5-Fluorouracil
RADIATION: Metabolic
OTHER: Metabolic
PROCEDURE: Surgery

Sponsor

Jules Bordet Institute

Collaborators

[object Object]